# Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)

> **NCT02435303** · PHASE2,PHASE3 · TERMINATED · sponsor: **Asan Medical Center** · enrollment: 2 (actual)

## Conditions studied

- Hypertension, Pulmonary
- Diseases of Mitral Valve

## Interventions

- **DRUG:** Sildenafil
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02435303
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05
- **Primary completion:** 2018-06
- **Final completion:** 2018-06
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Number of candidates for this study is expected to be too small.
- **Last updated:** 2019-07-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02435303

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02435303, "Effect of Sildenafil for Sustained PAH After MV Surgery (SUPERIOR Trial)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02435303. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*